Your browser doesn't support javascript.
loading
Transparent machine learning suggests a key driver in the decision to start insulin therapy in individuals with type 2 diabetes.
Musacchio, Nicoletta; Zilich, Rita; Ponzani, Paola; Guaita, Giacomo; Giorda, Carlo; Heidbreder, Rebeca; Santin, Pierluigi; Di Cianni, Graziano.
Affiliation
  • Musacchio N; AMD past President - AMD AI National Group Coordinator, Milan, Italy.
  • Zilich R; Mix-x SRL, Ivrea, Italy.
  • Ponzani P; Diabetes and Endocrinology Unit, Local Health Autlhority 4 Chiavari, Chiavari, Italy.
  • Guaita G; Diabetes and Endocrinology Unit, ASL SULCIS, Iglesias, Italy.
  • Giorda C; Diabetes and Endocrinology Unit, ASL TO5, Chieri, Italy.
  • Heidbreder R; PsychResearchCenter, LLC, Powhatan, Virginia, USA.
  • Santin P; Deimos, Udine, Italy.
  • Di Cianni G; USL Tuscany Northwest Location Livorno, Diabetes and Metabolic Disease, Livorno, Italy.
J Diabetes ; 15(3): 224-236, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36889912
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Diabetes Journal subject: ENDOCRINOLOGIA Year: 2023 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Diabetes Journal subject: ENDOCRINOLOGIA Year: 2023 Type: Article Affiliation country: Italy